electroCore to Present at 34th Annual Roth Conference
07 Março 2022 - 6:01PM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a
commercial-stage bioelectronic medicine company, today announced
that its management team will be presenting at the 34th Annual Roth
Conference. Details for access to the presentation are as follows:
Roth Conference:Date: Monday, March 14,
2022 Time: 8:30 AM PDTInvestors can register for the
conference HERE.
Following the conference, a webcast replay of the presentation
will be available on the Investor section of the company’s website,
electroCore.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its non-invasive vagus nerve
stimulation therapy platform, initially focused on the treatment of
multiple conditions in neurology. The company's current indications
are the preventive treatment of cluster headache and migraine, the
acute treatment of migraine and episodic cluster headache, the
acute and preventive treatment of migraines in adolescents, and
paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Investors:Rich CockrellCG
Capital404-736-3838ecor@cg.capitalorMedia
Contact:Jackie
DorskyelectroCore908-313-6331Jackie.dorsky@electrocore.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024